|
BQS-Bundesauswertung
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Herzschrittmacher-Implantation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualitätsindikator
3: Leitlinienkonforme Systemwahl bei bradykarden Herzrhythmusstörungen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualitätsziel: |
|
|
Möglichst oft leitlinienkonforme¹ Wahl eines
Herzschrittmachers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei bradykarden Herzrhythmusstörungen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grundgesamtheit: |
|
Alle Patienten (außer führende Indikation zur
Herzschrittmacherimplantation |
|
|
|
|
|
|
|
|
|
|
|
|
|
„kardiale Resynchronisationstherapie“ oder
„sonstiges“) mit implantiertem |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ein- oder Zweikammersystem |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kennzahl-ID: |
|
|
2006/09n1-HSM-IMPL/75973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Referenzbereich: |
|
>= 90% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gesamt 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patienten mit leitlinienkonformer¹ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Systemwahl zum Schrittmacher |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(I bis IIb) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sinusknotensyndrom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AV-Block oder faszikulären |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leitungsstörungen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bradykardie bei permanentem |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorhofflimmern |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Karotis-Sinus-Syndrom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vasovagalem Syndrom |
|
|
|
|
|
|
|
|
|
|
|
56.187 / 60.862 |
|
|
92,32% |
|
|
|
Vertrauensbereich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92,10% - 92,53% |
|
|
|
Referenzbereich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
>= 90% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patienten
mit nicht leitlinienkonformer¹ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Systemwahl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.675 / 60.862 |
|
|
7,68% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indikation (I bis
IIb) gemäß Leitlinie |
|
|
|
|
keine Indikation
gemäß Leitlinie |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorjahresdaten |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gesamt 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ein Vergleich zum Vorjahr ist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
aufgrund des neuen Datensatzes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 nicht möglich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¹ |
Leitlinien zur Herzschrittmachertherapie,
Deutsche Gesellschaft für Kardiologie, Herz- und Kreislaufforschung (Lemke et
al. 2005) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verteilung der Krankenhausergebnisse
[Diagramm 3, Kennzahl-ID 2006/09n1-HSM-IMPL/75973]: |
|
|
|
|
|
|
Anteil von Patienten mit leitlinienkonformer
Systemwahl zum Herzschrittmacher an allen Patienten |
|
|
|
|
|
(außer führende Indikation zur
Herzschrittmacherimplantation „kardiale Resynchronisationstherapie“ |
|
|
|
|
oder „sonstiges“) mit implantiertem Ein- oder
Zweikammersystem |
|
|
|
|
|
|
|
|
|
|
|
|
3 Krankenhäuser haben keinen Fall in dieser
Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Krankenhäuser mit mindestens 20 Fällen in
dieser Grundgesamtheit: |
|
|
|
|
|
|
|
|
|
|
|
|
Minimum - Maximum der Krankenhausergebnisse:
38,5% - 100,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Median der Krankenhausergebnisse: 93,9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
823 Krankenhäuser haben mindestens 20 Fälle
in dieser Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Krankenhäuser mit weniger als 20 Fällen in
dieser Grundgesamtheit: |
|
|
|
|
|
|
|
|
|
|
|
|
Minimum - Maximum der Krankenhausergebnisse:
0,0% - 100,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Median der Krankenhausergebnisse: 94,1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197 Krankenhäuser haben weniger als 20 Fälle
in dieser Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Systemwahl bei Sinusknotensyndrom (SSS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grundgesamtheit: |
|
Alle Patienten mit Sinusknotensyndrom (SSS)
als führende Indikation zur |
|
|
|
|
|
|
|
|
|
|
|
|
|
Herzschrittmacherimplantation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gesamt 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patienten |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
|
mit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
AAI |
|
|
indiziert¹ |
|
|
|
|
|
|
|
|
|
|
|
293 / 543 |
|
|
53,96% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2) |
VVI |
|
|
indiziert² |
|
|
|
|
|
|
|
|
|
|
|
1.005 / 2.781 |
|
|
36,14% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3) |
DDD |
|
|
indiziert³ |
|
|
|
|
|
|
|
|
|
|
18.001 / 18.109 |
|
|
99,40% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4) |
VDD |
|
|
indiziert* |
|
|
|
|
|
|
|
|
|
|
|
|
0 / 76 |
|
|
0,00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summe aus 1) bis 4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leitlinienkonforme** Systemwahl bei |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sinusknotensyndrom (SSS) |
|
|
|
|
|
|
|
|
|
|
|
19.299 / 21.509 |
|
|
89,73% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nicht
leitlinienkonforme** Systemwahl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Sinusknotensyndrom (SSS) |
|
|
|
|
|
|
|
|
|
|
|
2.210 / 21.509 |
|
|
10,27% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indikation Klasse I
bis IIb gemäß Leitlinie |
|
|
keine Indikation
gemäß Leitlinie |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Erläuterungen s. nächste Seite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Erläuterungen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<
